To the central content area :::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6712 Ever Supreme
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Liu Chu-Chi Huang Wen-Liang Hsu, Chin-Ting 04-23252888 4F., No.30, Keya Rd., Daya Dist.Taichung City, Taiwan (R.O.C.) 2021/01/08
Industry Main Business
Biotechnology and Medical Care Devote to organize R&D professionals in cell gene therapy to help the needs for recovering health and improving quality of life. Endeavor to ambitiously achieve a particular goal in becoming top cell pharmaceutical companies in the Asia-Pacific Region and to seek partnership and collaboration with experts as a solution provider.
Market Information ( 2023/09/22 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
1715.076 204.00  194.00  194.00  -3.00  14574 3,248 19
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N Y Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.